Delayed-type hypersensitivity reaction or serum sickness after rituximab treatment.
Hellerstedt
B
B
Ahmed
A
A
D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004342:Drug Hypersensitivity; D005260:Female; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000139:chemically induced*; D008180:Lupus Erythematosus, Systemic / Q000150:complications; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D000069283:Rituximab; D012713:Serum Sickness / Q000139:chemically induced*
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab